FDA Pushes Final Generic Labeling Rule To July
The U.S. Food and Drug Administration has pushed back to July the release of a final rule allowing generic-drug makers to update safety labels detailing new risks without agency approval. ...To view the full article, register now.
Already a subscriber? Click here to view full article